Cas:7042-02-6 Methyl 4-butanolide-4-carboxylate manufacturer & supplier

We serve Chemical Name:Methyl 4-butanolide-4-carboxylate CAS:7042-02-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 4-butanolide-4-carboxylate

Chemical Name:Methyl 4-butanolide-4-carboxylate
CAS.NO:7042-02-6
Synonyms:Methyl 4-butanolide-4-carboxylate
Molecular Formula:C6H8O4
Molecular Weight:144
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl 4-butanolide-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 4-butanolide-4-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 4-butanolide-4-carboxylate Use and application,Methyl 4-butanolide-4-carboxylate technical grade,usp/ep/jp grade.


Related News: With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. Methyl 4-butanolide-4-carboxylate manufacturer In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant. Methyl 4-butanolide-4-carboxylate supplier Both were in Siberia, and both are Chinese nationals who had recently traveled to China. Methyl 4-butanolide-4-carboxylate vendor It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation. Methyl 4-butanolide-4-carboxylate factory With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.